All studies
Enrolling by invitationOBSERVATIONAL

Lead Evaluation for Defibrillation and Reliability Post Approval Study

This study, called LEADR PAS, is observing how a specific medical device, the OmniaSecure™ defibrillation lead, performs once it's available for general use. These leads are tiny wires that help control very fast or irregular heartbeats (tachyarrhythmia). The main goal is to keep track of its safety and how well it works over time in real-world situations. It’s not testing a new device, but rather gathering information on one that's already in use. Patients who receive this lead as part of their standard care will have their health and the device's performance monitored. This helps doctors and manufacturers ensure the device continues to be safe and effective for people needing it.

At a glance

Status
Enrolling by invitation
Sponsor
Medtronic
Enrolment target
2,000
Start
07 Jan 2026
Estimated completion
01 Sep 2032

What is this study about?

This study is called the LEADR PAS, which stands for "Lead Evaluation for Defibrillation and Reliability Post Approval Study." It's being run by Medtronic, the company that makes a specific type of medical device called an OmniaSecure™ defibrillation lead. These leads are like tiny wires that are a crucial part of an implantable heart device. They are designed to deliver a small electric shock to correct very fast or irregular heartbeats, a condition sometimes called tachyarrhythmia, which can be dangerous.

Unlike trials that test new medicines or devices, this study is observing how the OmniaSecure™ defibrillation lead performs after it has already been approved and is being used by patients in their regular healthcare. Think of it like watching how a new car model performs once it's on the road with many drivers, rather than just in test drives. The main purpose is to make sure the device continues to be safe and effective for patients in their everyday lives over many years.

Doctors and the company want to collect ongoing information about these leads. By following a large group of patients over a long period, they can gather important details about the device's reliability and any potential issues that might come up. This information helps them confirm that the device is working as expected and allows them to make any necessary improvements to ensure the best possible care for patients.

Key takeaways

  • This study tracks the long-term safety of a specific heart device.
  • It helps ensure the OmniaSecure™ defibrillation lead works well for patients.
  • Participation involves routine doctor's visits, not extra procedures.
  • The study observes a device already in use, not a new treatment.
  • Your contribution helps improve care for others with heart conditions.
  • You can stop participating at any time.

Who may be eligible?

To be part of this study, you would first need to agree to participate by signing a consent form. This makes sure you understand what the study involves.

Next, you must have either just received, or be about to receive, an OmniaSecure™ defibrillation lead as part of your heart treatment. It's important that your doctor plans for you to have this specific lead.

You would not be able to join if it would be difficult for doctors to keep in touch with you for follow-up appointments. Also, if you are already taking part in another medical study that might affect the results of this one, you might not be able to join. Finally, any local laws or rules could also affect whether you can participate.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. Have I signed a consent form to join?
  2. Am I receiving, or about to receive, an OmniaSecure™ defibrillation lead?
  3. Can doctors easily contact me for follow-up appointments?
  4. Am I currently in any other medical studies that might prevent me from joining this one?
Answer every question to see your result.

What does participation involve?

If you decide to join this study, it would mostly involve your regular doctor's appointments. You would be followed for as long as you have the defibrillation lead implanted, or until the study officially ends, or if you choose to leave the study at any time.

This means you would attend your usual scheduled check-ups, typically at least once a year. Your doctors would keep an eye on your health and how the defibrillation lead is working, just as they would as part of your routine care. If there are any important health events, those would also be recorded. The study aims to follow patients for many years, potentially for the entire lifetime of the device.

Potential risks and benefits

The main benefit of participating is contributing valuable information that helps medical professionals understand the long-term safety and effectiveness of this important heart device for many others. Since this study observes a device already in use, it does not involve new treatments or procedures beyond your standard medical care. Therefore, there are no additional medical risks from the study itself beyond those associated with receiving the defibrillation lead as part of your usual treatment. You have the right to withdraw from the study at any time without affecting your medical care.

Locations (73)

  • The University of Alabama at Birmingham
    Verified postcode
    Birmingham, United States
  • Stanford Hospital & Clinics
    Verified postcode
    Stanford, United States
  • COR Healthcare
    Verified postcode
    Torrance, United States
  • Childrens Hospital Colorado
    Verified postcode
    Aurora, United States
  • Hartford Hosptial
    Verified postcode
    Hartford, United States
  • Childrens National Medical Center
    Verified postcode
    Washington D.C., United States
  • Heart Rhythm Solutions
    Verified postcode
    Hollywood, United States
  • Cardiovascular Institute of Northwest Florida
    Verified postcode
    Panama City, United States
  • Heart & Vascular Institute of Florida
    Verified postcode
    Safety Harbor, United States
  • Intercoastal Medical Group
    Verified postcode
    Sarasota, United States
  • University of South Florida Health (USF)
    Verified postcode
    Tampa, United States
  • WellStar Research Institute
    Verified postcode
    Marietta, United States

Common questions

What is a defibrillation lead?

It's a special wire that's part of a heart device. It helps correct very fast or irregular heartbeats by delivering a small electric pulse.

Is this a trial for a new treatment?

No, this study is observing how a defibrillation lead that is already approved and in use performs in real-world patients over time.

How long will I be in the study?

You'll be followed for as long as you have the device, or until the study ends, or if you choose to stop participating.

Do I need extra appointments for this study?

Generally, you will attend your regular, routine follow-up appointments with your doctor, typically at least once a year.

Can I leave the study at any time?

Yes, you are free to withdraw from the study at any point without it affecting your medical care.

How to find out more

Always speak to your GP or specialist before deciding to take part in a study.

Interested in taking part?

Register your interest

Share your details and the research team for "Lead Evaluation for Defibrillation and Reliability Post Appr…" will contact you if you may be eligible. Always speak to your GP before agreeing to take part.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.